Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Roflumilast in Pruritus: NCT07560618 Clinical Landscape Report 2026
9 min read
Roflumilast in Pruritus: NCT07560618 Clinical Landscape Report 2026
18 September 2026
NCT07560618 clinical landscape for Pruritus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
RO-7851624 in Multiple Myeloma: NCT07558915 Clinical Landscape Report 2026
9 min read
RO-7851624 in Multiple Myeloma: NCT07558915 Clinical Landscape Report 2026
18 September 2026
NCT07558915 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Ixekizumab in Plaque psoriasis: ISRCTN91905052 Clinical Landscape Report 2026
9 min read
Ixekizumab in Plaque psoriasis: ISRCTN91905052 Clinical Landscape Report 2026
18 September 2026
ISRCTN91905052 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Daunorubicin Hydrochloride in Acute Myeloid Leukemia: NCT07561892 Clinical Landscape Report 2026
9 min read
Daunorubicin Hydrochloride in Acute Myeloid Leukemia: NCT07561892 Clinical Landscape Report 2026
18 September 2026
NCT07561892 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Busulfan in leukemia acute ambiguous lineage: NCT07565220 Clinical Landscape Report 2026
9 min read
Busulfan in leukemia acute ambiguous lineage: NCT07565220 Clinical Landscape Report 2026
18 September 2026
NCT07565220 clinical landscape for leukemia acute ambiguous lineage: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
Fludarabine Phosphate in Acute Myeloid Leukemia: NCT07563920 Clinical Landscape Report 2026
9 min read
Fludarabine Phosphate in Acute Myeloid Leukemia: NCT07563920 Clinical Landscape Report 2026
18 September 2026
NCT07563920 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
[68Ga]Ga-R54 in Advanced Malignant Solid Neoplasm: NCT07577206 Clinical Landscape Report 2026
9 min read
[68Ga]Ga-R54 in Advanced Malignant Solid Neoplasm: NCT07577206 Clinical Landscape Report 2026
18 September 2026
NCT07577206 clinical landscape for Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
Read →
JNJ-95804306 in Acute Myeloid Leukemia: NCT07572006 Clinical Landscape Report 2026
9 min read
JNJ-95804306 in Acute Myeloid Leukemia: NCT07572006 Clinical Landscape Report 2026
18 September 2026
NCT07572006 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Nubytide in Alzheimer Disease: NCT07568041 Clinical Landscape Report 2026
9 min read
Nubytide in Alzheimer Disease: NCT07568041 Clinical Landscape Report 2026
18 September 2026
NCT07568041 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Etomidate in Ovarian Cancer: ISRCTN10813814 Clinical Landscape Report 2026
9 min read
Etomidate in Ovarian Cancer: ISRCTN10813814 Clinical Landscape Report 2026
18 September 2026
ISRCTN10813814 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
TCX-102 in Relapsing acute myeloid leukemia: NCT07566585 Clinical Landscape Report 2026
9 min read
TCX-102 in Relapsing acute myeloid leukemia: NCT07566585 Clinical Landscape Report 2026
18 September 2026
NCT07566585 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
Flortaucipir F-18 in Alzheimer Disease: NCT07580703 Clinical Landscape Report 2026
9 min read
Flortaucipir F-18 in Alzheimer Disease: NCT07580703 Clinical Landscape Report 2026
18 September 2026
NCT07580703 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →